Buprenorphine
NDC 50268-129, Buprenorphine, tablet, from AvPAK.
- Product NDC
- 50268-129
- Status
- Listed
- Labeler
- AvPAK
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201760
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/50268-129 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE HYDROCHLORIDE8 mg/1
Pharmacologic classes
Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50268-129-15 | 50268012915 | 50 BLISTER PACK in 1 BOX (50268-129-15) / 1 TABLET in 1 BLISTER PACK (50268-129-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1408cd8f-a0b5-6be7-e063-6394a90a0b41NADAC price for package 50268012915
GET /v1/drugs/nadac/50268012915
Use it
Look up 50268-129 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50268-129 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50268-129. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.